NewslettersCell Therapy News IL-36γ Armored CAR T Cells Reprogram Neutrophils to Induce Endogenous Antitumor Immunity By Noshin Noorjahan - December 15, 2025 0 33 Researchers reported that IL-36γ armored CAR T cells eradicate primary solid tumors and enable rejection of rechallenged antigen-negative tumors. [Cancer Cell] AbstractGraphical Abstract